Scheduled Intranasal Ketamine
NCT05671913 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL
Last updated 2023-04-05
Summary
The purpose of this research is to determine if scheduled intranasal ketamine effects opioid requirements in adult trauma patients with moderate to severe pain in the inpatient setting.
Conditions
Interventions
Sponsors & Collaborators
-
Sanford Health
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-01
- Primary Completion
- 2025-12-31
- Completion
- 2026-01-01
More Related Trials
-
Subdissociative Dose Ketamine for Treatment of Acute Pain in Subjects With Chronic Pain
NCT02920528 ·Status: COMPLETED ·Phase: PHASE3
-
Ketamine for the Treatment of Opioid Use Disorder and Depression
NCT04177706 ·Status: COMPLETED ·Phase: PHASE2
-
Nasal Human Abuse Potential of PTI-821
NCT03475862 ·Status: COMPLETED ·Phase: PHASE1
-
Ketamine for Opioid Use Disorder
NCT06943859 ·Status: RECRUITING ·Phase: PHASE2
-
Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder
NCT02044094 ·Status: COMPLETED ·Phase: PHASE2
-
Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED
NCT06364540 ·Status: RECRUITING ·Phase: PHASE4
-
Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder
NCT04495673 ·Status: TERMINATED ·Phase: NA
-
NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study
NCT02692157 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Study for Naltrexone on the Abuse Potential of Methylphenidate
NCT03769064 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults
NCT05377255 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers
NCT02572089 ·Status: COMPLETED ·Phase: PHASE1
-
Naloxone and Intravenous Methylnaltrexone Effects on Bladder Function
NCT01367561 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacodynamic Evaluation of Intranasal Nalmefene
NCT04828005 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
NCT01841931 ·Status: TERMINATED ·Phase: PHASE4
-
Pharmacogenetics of Naltrexone for Stimulant Abuse
NCT03226223 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, and Pharmacokinetics of CSX-1004
NCT06005402 ·Status: COMPLETED ·Phase: PHASE1
-
Opiate Suicide Study in Patients With Major Depression
NCT04116528 ·Status: COMPLETED ·Phase: PHASE3
-
Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists
NCT05338632 ·Status: RECRUITING ·Phase: PHASE1
-
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
NCT00134914 ·Status: COMPLETED ·Phase: NA
-
Safety of Subcutaneous Methylnaltrexone for Opioid-Induced Constipation in Patients With Advanced Illness
NCT00672139 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study of the Bioavailability of Nasal Naloxone
NCT01939444 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Study Investigating the Safety, Tolerability and Pharmacokinetics of KNX100 in Healthy Volunteers
NCT04901078 ·Status: COMPLETED ·Phase: PHASE1
-
Feasibility Study of Oral Naloxone for Treatment of Methadone-induced Constipation
NCT02137213 ·Status: COMPLETED ·Phase: PHASE2
-
Suvorexant for Opioid/Stimulant Co-use
NCT05546515 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics of Intravenous and Intranasal Formulations of Naloxone in Healthy Volunteers.
NCT06306391 ·Status: COMPLETED ·Phase: PHASE1